ANCA-associated vasculitis

显微镜下多血管炎 蛋白酶3 自身抗体 嗜酸性 血管炎 抗中性粒细胞胞浆抗体 髓过氧化物酶 免疫学 肉芽肿伴多发性血管炎 发病机制 疾病 医学 抗体 炎症 病理
作者
Arthur Richard Kitching,Hans‐Joachim Anders,Neil Basu,Elisabeth Brouwer,Jennifer Gordon,David R.W. Jayne,Joyce A Kullman,Paul Lyons,Peter A. Merkel,Caroline O. S. Savage,Ulrich Specks,Renate Kain
出处
期刊:Nature Reviews Disease Primers [Nature Portfolio]
卷期号:6 (1): 71-71 被引量:1031
标识
DOI:10.1038/s41572-020-0204-y
摘要

The anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitides (AAVs) are a group of disorders involving severe, systemic, small-vessel vasculitis and are characterized by the development of autoantibodies to the neutrophil proteins leukocyte proteinase 3 (PR3-ANCA) or myeloperoxidase (MPO-ANCA). The three AAV subgroups, namely granulomatosis with polyangiitis (GPA), microscopic polyangiitis and eosinophilic GPA (EGPA), are defined according to clinical features. However, genetic and other clinical findings suggest that these clinical syndromes may be better classified as PR3-positive AAV (PR3-AAV), MPO-positive AAV (MPO-AAV) and, for EGPA, by the presence or absence of ANCA (ANCA+ or ANCA–, respectively). Although any tissue can be involved in AAV, the upper and lower respiratory tract and kidneys are most commonly and severely affected. AAVs have a complex and unique pathogenesis, with evidence for a loss of tolerance to neutrophil proteins, which leads to ANCA-mediated neutrophil activation, recruitment and injury, with effector T cells also involved. Without therapy, prognosis is poor but treatments, typically immunosuppressants, have improved survival, albeit with considerable morbidity from glucocorticoids and other immunosuppressive medications. Current challenges include improving the measures of disease activity and risk of relapse, uncertainty about optimal therapy duration and a need for targeted therapies with fewer adverse effects. Meeting these challenges requires a more detailed knowledge of the fundamental biology of AAV as well as cooperative international research and clinical trials with meaningful input from patients. The anti-neutrophil cytoplasmic antibody-associated vasculitides (AAVs) are autoimmune disorders characterized by inflammation and destruction of small blood vessels. In this Primer, the authors discuss the classification of AAVs and the pathogenetic mechanisms, diagnosis and treatment of these debilitating conditions.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
在水一方的应助被pivot_literature采纳,获得10
1秒前
顺顺顺完成签到 ,获得积分10
1秒前
eating完成签到,获得积分10
2秒前
璐璐完成签到,获得积分10
2秒前
hky发布了新的文献求助10
2秒前
pillowdamon发布了新的文献求助10
4秒前
mix完成签到,获得积分10
5秒前
路明非完成签到,获得积分10
7秒前
rslysywd完成签到,获得积分10
7秒前
8秒前
8秒前
可爱的函函的应助被演九胜采纳,获得10
13秒前
13秒前
shi完成签到,获得积分10
13秒前
shaofeng发布了新的文献求助10
14秒前
红烧肉发布了新的文献求助10
14秒前
王亚奇的应助被wyy采纳,获得20
15秒前
旺旺完成签到,获得积分10
15秒前
yyy2025完成签到,获得积分10
15秒前
16秒前
虚拟的画板完成签到 ,获得积分10
18秒前
端庄的小蝴蝶完成签到,获得积分10
20秒前
慕青的应助被坚强孤容采纳,获得10
22秒前
打打的应助被旺旺采纳,获得10
22秒前
wy.he完成签到,获得积分0
24秒前
如梦如画完成签到,获得积分10
24秒前
Teddy完成签到,获得积分10
24秒前
祁絢完成签到,获得积分10
25秒前
激流勇进wb完成签到 ,获得积分10
28秒前
29秒前
30秒前
天真南松完成签到,获得积分10
32秒前
YUHL完成签到 ,获得积分10
32秒前
简生pro完成签到,获得积分10
32秒前
饭特稀完成签到,获得积分10
33秒前
天天向上的应助被蟹老板采纳,获得10
33秒前
xing_xing的应助被科研通管家采纳,获得20
33秒前
Jasper的应助被科研通管家采纳,获得10
33秒前
33秒前
33秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8186784
求助须知:如何正确求助?哪些是违规求助? 9575092
关于积分的说明 21839541
捐赠科研通 7784418
什么是DOI,文献DOI怎么找? 3434819
关于科研通互助平台的介绍 2559221
邀请新用户注册赠送积分活动 2481682